Omeprazol Cf (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Cf, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Omeprazol Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is available for bulk procurement. We ensure timely delivery and regulatory support for each order.

Omeprazole is a proton pump inhibitor that reduces gastric acid production, making it useful for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining a higher gastric pH. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication (as part of combination therapy): enhances antibiotic effectiveness by reducing gastric acidity. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Abdominal pain: discomfort or cramping in the upper abdomen. - Nausea: feeling of queasiness without vomiting. - Diarrhea: loose stools occurring intermittently. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low serum magnesium causing muscle cramps or arrhythmia. - Vitamin B12 deficiency: long‑term use may impair absorption. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Bone fractures: increased risk with prolonged therapy.

Before initiating therapy, consider the following safety measures.

- Assess renal function: dose adjustment may be required in severe impairment. - Monitor hepatic status: use with caution in patients with liver disease. - Limit duration: avoid long‑term use without medical supervision. - Review concomitant antiplatelet therapy: increased bleeding risk may occur. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atorvastatin: increased statin exposure, raising risk of myopathy. - Methotrexate: elevated plasma levels, potentially causing toxicity. - Warfarin: variable INR changes, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Digoxin: decreased absorption, may reduce therapeutic effect. - Diazepam: increased serum concentrations, leading to enhanced sedation. - Ketoconazole: reduced absorption, compromising antifungal efficacy.